Esomeprazole Market Expected to Grow at a CAGR of 5.3% During the Forecast Period 2024-2032

𝐄𝐬𝐨𝐦𝐞𝐩𝐫𝐚𝐳𝐨𝐥𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

The esomeprazole market is driven by factors such as the prevalence of gastrointestinal disorders, increasing awareness about effective treatment options, and the availability of generic versions of esomeprazole, which offer cost-effective alternatives to branded formulations. Esomeprazole is available in various forms, including oral capsules, tablets, and intravenous formulations.

The global esomeprazole market size is expected to reach USD 2,872.07 million by 2032, according to a new study by Polaris Market Research. The report "Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Esomeprazole is gaining importance in the global healthcare space attributable to the prevalence of gastric ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and more in the world. The higher effectiveness of esomeprazole in lowering acid in the stomach among humans is a contributing factor fueling the expansion of the esomeprazole market in the coming years.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/esomeprazole-market/request-for-sample

The increasing gastrointestinal problems in people are showcasing the significant demand for esomeprazole, as it is widely utilized in the treatment process. According to the 2023 study, people infected with COVID-19 have a higher risk (39%) of developing gastroesophageal reflux disease in the year, followed by the infection in line with the people who are not infected by the COVID-19 virus. This study demonstrates new growth opportunities for the market during the study period.

The emergence of market players entering the production of esomeprazole in the marketplace is likely to enhance the esomeprazole market size in the coming years. For instance, in 2023, Granules India Limited received the approval of an abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules for USP, 20 mg, and 40mg strengths from the US Food and Drug Administration (US FDA). These initiatives are expected to enhance the supply of this drug on the market.

Pharmaceutical companies are boosting research and development activities to innovate effective medication for the numerous unresolved health issues, including gastric and duodenal ulcers. For instance, in April 2023, Akums Drugs and Pharmaceuticals introduced the new Combikit for the treatment of H. pylori infection and duodenal ulcer. These developments are likely to create new esomeprazole market opportunities around the world.

The increased accessibility of the internet lowered the chance of asymmetry of information in the world, driving enhanced knowledge of medicines. The rising stomach-related issues in the population are likely to facilitate significant demand for the esomeprazole drug through the over-the-counter option in the marketplace during the forecast period.

More companies are entering into the production of pharmaceutical drugs, specifically esomeprazole, driving the expansion of the global market. For instance, in October 2023, Marksans received approval to produce esomeprazole magnesium capsules.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

𝐏𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐆𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬:

The high prevalence of gastrointestinal conditions such as GERD, peptic ulcers, and gastritis drives the demand for esomeprazole and other PPI medications. These conditions affect millions of people worldwide, leading to symptoms such as heartburn, acid reflux, and stomach pain, which can significantly impact quality of life and require effective treatment options like esomeprazole.

𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐚𝐧𝐝 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬:

Growing awareness about the symptoms and consequences of gastrointestinal disorders, coupled with improved diagnostic methods, leads to increased diagnosis rates and treatment-seeking behavior among patients. As a result, there is a higher demand for medications like esomeprazole to manage these conditions and alleviate symptoms effectively.

𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐨𝐟 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐕𝐞𝐫𝐬𝐢𝐨𝐧𝐬:

The availability of generic esomeprazole formulations offers cost-effective treatment options for patients and healthcare providers. Generic versions of esomeprazole are often more affordable than branded formulations, making them accessible to a broader population and driving market growth.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/buy/3314/2

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:

𝐆𝐚𝐬𝐭𝐫𝐨𝐞𝐬𝐨𝐩𝐡𝐚𝐠𝐞𝐚𝐥 𝐑𝐞𝐟𝐥𝐮𝐱 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 (𝐆𝐄𝐑𝐃):

GERD is one of the primary applications of esomeprazole. It is used to treat symptoms such as heartburn, acid reflux, and regurgitation by reducing stomach acid production and promoting healing of the esophagus. Esomeprazole provides effective relief and helps improve the quality of life for individuals suffering from GERD.

𝐏𝐞𝐩𝐭𝐢𝐜 𝐔𝐥𝐜𝐞𝐫𝐬:

Esomeprazole is also used in the treatment of peptic ulcers, including gastric ulcers and duodenal ulcers. By reducing stomach acid production, esomeprazole helps alleviate ulcer symptoms such as abdominal pain, bloating, and nausea, and promotes healing of the ulcerated mucosa.

𝐇𝐞𝐥𝐢𝐜𝐨𝐛𝐚𝐜𝐭𝐞𝐫 𝐩𝐲𝐥𝐨𝐫𝐢 𝐄𝐫𝐚𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲:

Esomeprazole is often used as part of combination therapy to eradicate Helicobacter pylori (H. pylori) bacteria, which are associated with the development of peptic ulcers and gastritis. Esomeprazole helps enhance the effectiveness of antibiotic therapy by reducing gastric acid secretion, thereby creating a favorable environment for bacterial eradication.

𝐄𝐬𝐨𝐦𝐞𝐩𝐫𝐚𝐳𝐨𝐥𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

Capsules segment is anticipated to witness the highest growth in the coming years due to its superior action over tablets.

Gastroesophageal reflux disease segment accounted for the largest market share owing to the rising incidence of acid reflux cases.

Hospitals & Clinical Pharmacies segment is projected to experience a larger revenue share attributable to the increased patient access.

APAC is projected to register the fastest growth during the forecast period attributable to the presence of the elderly population.

The global players include Actavis, AstraZeneca AB, Blaskov, CQ Lummy, KernPharm, Mepha, Mylan, Sandoz, Sanofi, Saval Pharmaceutical, Stada, & Teva.

𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐭𝐡𝐞 𝐞𝐬𝐨𝐦𝐞𝐩𝐫𝐚𝐳𝐨𝐥𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐩𝐫𝐨𝐝𝐮𝐜𝐭, 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝐝𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐚𝐧𝐝 𝐫𝐞𝐠𝐢𝐨𝐧:

𝐄𝐬𝐨𝐦𝐞𝐩𝐫𝐚𝐳𝐨𝐥𝐞, 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)

Capsules
Tablets
Injections
Others

𝐄𝐬𝐨𝐦𝐞𝐩𝐫𝐚𝐳𝐨𝐥𝐞, 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)

Gastroesophageal reflux disease
Erosive Esophagitis
Peptic Ulcers
Duodenal Ulcers
Zollinger-Ellison Syndrome
Others

𝐄𝐬𝐨𝐦𝐞𝐩𝐫𝐚𝐳𝐨𝐥𝐞, 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)

Hospitals & Clinical Pharmacies
Online Pharmacies
OTC

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐚𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐚𝐧𝐝 𝐏𝐫𝐢𝐜𝐢𝐧𝐠 @ https://www.polarismarketresearch.com/industry-analysis/esomeprazole-market/request-for-discount-pricing

𝐓𝐡𝐞 𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐂𝐨𝐯𝐞𝐫𝐬 𝐅𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐊𝐞𝐲 𝐑𝐞𝐠𝐢𝐨𝐧𝐬:

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and the Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and the rest of South America)

The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa, and the Rest of the Middle East and Africa)

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐌𝐨𝐫𝐞:

𝐒𝐚𝐭𝐞𝐥𝐥𝐢𝐭𝐞 𝐏𝐫𝐨𝐩𝐮𝐥𝐬𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/satellite-propulsion-system-market-propelling-space-fsmif

𝐔𝐥𝐭𝐫𝐚𝐯𝐢𝐨𝐥𝐞𝐭 𝐃𝐢𝐬𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/ultraviolet-disinfection-equipment-market-harnessing-uv-mohit-harne-ri2ff

𝐁𝐫𝐨𝐦𝐞𝐥𝐚𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/bromelain-market-exploring-enzymatic-potential-4vshf

𝐌𝐮𝐬𝐬𝐞𝐥 𝐎𝐢𝐥 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/mussel-oil-market-unlocking-health-benefits-from-marine-zuytf

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:

Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.